Literature DB >> 7048169

[Treatment of refractory cytostatic agent-induced vomiting with the synthetic cannabinoid levonantradol].

M E Heim, W Queisser.   

Abstract

20 patients with malignant tumours with severe gastrointestinal side effects during cancer chemotherapy refractory to standard antiemetic drugs were treated with the cannabinoid levonantradol in a second identical chemotherapy course. 17 patients (85%) has less nausea and vomiting, 5 had a total relief of symptoms, and 8 had a reduction of frequency of vomiting of 50% or more. Side effects were frequent, whereby fatigue, dizziness (12/20) and psychical side effects (8/20) were found to be the most uncomfortable.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7048169     DOI: 10.1159/000214975

Source DB:  PubMed          Journal:  Onkologie        ISSN: 0378-584X


  3 in total

1.  Levonantradol for the treatment of chemotherapy-induced nausea and vomiting.

Authors:  H H Gerhartz; T Binsack; E Hiller
Journal:  Klin Wochenschr       Date:  1983-07-15

2.  [New aspects in the antiemetic therapy of cytostatic drug-induced vomiting].

Authors:  E Hiller; H Gerhartz
Journal:  Klin Wochenschr       Date:  1984-05-15

3.  Randomized crossover study of the antiemetic activity of levonantradol and metoclopramide in cancer patients receiving chemotherapy.

Authors:  M E Heim; W Queisser; H P Altenburg
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.